1. Home
  2. JAGX vs SPRC Comparison

JAGX vs SPRC Comparison

Compare JAGX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$2.73

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$11.22

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
SPRC
Founded
2013
2004
Country
United States
Israel
Employees
47
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.5M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
JAGX
SPRC
Price
$2.73
$11.22
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
71.5K
1.2M
Earning Date
04-07-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$11,511,000.00
N/A
Revenue This Year
$61.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.29
52 Week High
$8.00
$15.79

Technical Indicators

Market Signals
Indicator
JAGX
SPRC
Relative Strength Index (RSI) 47.96 66.43
Support Level $1.74 $2.17
Resistance Level $4.13 N/A
Average True Range (ATR) 0.39 1.69
MACD -0.16 0.61
Stochastic Oscillator 2.11 61.92

Price Performance

Historical Comparison
JAGX
SPRC

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: